Results 321 to 330 of about 280,195 (357)
The Development and Application of Bispecific Antibodies in B-Cell Non-Hodgkin Lymphoma. [PDF]
J Pers MedSun L, Romancik JT.
europepmc +1 more source
B7-H7 knockdown suppresses the proliferation, metastasis, and drug resistance of B-cell non-Hodgkin lymphoma cells by inhibiting the PI3K/Akt pathway. [PDF]
Front OncolZhai A +7 more
europepmc +1 more source
Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma
Nature, 2011 Follicular lymphoma (FL) and diffuse large B-cell lymphoma (DLBCL) are the two most common non-Hodgkin lymphomas (NHLs). Here we sequenced tumour and matched normal DNA from 13 DLBCL cases and one FL case to identify genes with mutations in B-cell NHL ...
Ryan D Morin +2 more
exaly +2 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
PET/CT in Non-Hodgkin Lymphoma: An Update.
Seminars in nuclear medicine, 2022Non-Hodgkin lymphomas represents a heterogeneous group of lymphoproliferative disorders characterized by different clinical courses, varying from indolent to highly aggressive.
L. Zanoni +8 more
semanticscholar +1 more source
British medical journal, 2018
### What you need to know Non-Hodgkin lymphoma are malignant disorders arising from cells of the immune system, and manifest predominantly as lymphadenopathy or solid tumours. The classification of non-Hodgkin lymphoma is complex and ever-evolving, with
Anna Bowzyk Al-Naeeb +3 more
semanticscholar +1 more source
### What you need to know Non-Hodgkin lymphoma are malignant disorders arising from cells of the immune system, and manifest predominantly as lymphadenopathy or solid tumours. The classification of non-Hodgkin lymphoma is complex and ever-evolving, with
Anna Bowzyk Al-Naeeb +3 more
semanticscholar +1 more source